Longitudinal identification of clinically distinct neurophenotypes in young children with fragile X syndrome

Jennifer L Bruno1, David Romano1, Paul Mazaika2

  • 1Center for Interdisciplinary Brain Sciences Research, Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA 94305-5795; jenbruno@stanford.edu dromano@stanford.edu.

Insights

Fragile X syndrome (FXS) subgroups were identified using brain MRI scans. This neuroimaging approach revealed distinct developmental patterns, potentially aiding in personalized interventions for FXS patients.

Area of Science:

  • Neuroscience
  • Genetics
  • Developmental Biology

Background:

  • Fragile X syndrome (FXS), caused by FMR1 gene mutations, is a leading inherited cause of developmental disability.
  • Varied cognitive, behavioral, and neurological phenotypes in FXS complicate outcome prediction and intervention planning.
  • Identifying early biological markers is crucial for understanding FXS heterogeneity.

Purpose of the Study:

  • To investigate early structural brain growth patterns in young boys with FXS.
  • To identify distinct neuroanatomical subgroups within the FXS population using longitudinal MRI data.
  • To explore the potential of topological data analysis (TDA) for defining clinically relevant subtypes.

Main Methods:

  • Longitudinal T1-weighted anatomical MRI scans were acquired from 42 young boys with FXS at two time points (mean ages 2.89 and 4.91 years).
  • Topological data analysis (TDA), an unsupervised machine learning technique, was applied to the MRI data to identify subgroups.
  • Cognitive, adaptive functioning, and autism severity scores were compared between identified subgroups post hoc.

Main Results:

  • TDA successfully identified two distinct subgroups based solely on longitudinal brain MRI data.
  • One subgroup consistently demonstrated higher functioning across cognitive, adaptive, and autism severity measures at both time points.
  • Significant differences (P < 0.05) were observed between the subgroups, indicating neuroanatomically distinct and clinically relevant phenotypes.

Conclusions:

  • The study supports the existence of two longitudinally defined, neuroanatomically distinct phenotypes in boys with FXS.
  • Early structural brain growth, analyzed by TDA, can serve as a marker for identifying clinically meaningful subgroups.
  • This approach may enhance outcome prediction, guide targeted therapies for FXS, and potentially define subtypes in other neuropsychiatric disorders.